h1n1

Share

RMS performs risk analysis for Vita Capital IV swine flu cat bond

Risk Management Solutions have released a few more details about their role in the recent Swiss Re mortality transaction Vita Capital IV Ltd. The transaction gives Swiss Re more coverage to allow for any increased mortality which results from H1N1 swine flu.  It's the first deal of its kind being read the full article →

Swiss Re completes new Vita Capital IV Ltd. mortality bond

Swiss Re have now completed their latest life insurance securitization, Vita Capital IV Ltd. The mortality bond transaction provides Swiss Re with $75m of cover against severe population mortality in the U.S. or the UK. The deal covers a five-year risk period ending in 2014. The notes issued by Vita read the full article →